Firefly Neuroscience Inc (AIFF)
3.16 x 5 3.23 x 1
Post-market by (Cboe BZX)
3.18 unch (unch) 04/11/25 [NASDAQ]
3.16 x 5 3.23 x 1
Post-market 3.17 -0.01 (-0.31%) 17:17 ET
for Fri, Apr 11th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -10,460 | -2,603 | -17,754 | -1,131 | 413 |
Depreciation Amortization | 941 | N/A | 220 | 237 | 12 |
Income taxes - deferred | N/A | N/A | -3,019 | N/A | N/A |
Accounts receivable | -37 | -65 | 35 | 389 | -774 |
Accounts payable and accrued liabilities | 883 | 33 | -77 | -112 | -113 |
Other Working Capital | 445 | 136 | -119 | 433 | -30 |
Other Operating Activity | 2,073 | 327 | 14,700 | -551 | 914 |
Operating Cash Flow | $-6,155 | $-2,172 | $-6,014 | $-735 | $423 |
Cash Flows From Investing Activities | |||||
PPE Investments | -148 | N/A | -536 | -70 | -65 |
Net Acquisitions | N/A | N/A | N/A | -9,512 | N/A |
Purchase Sale Intangibles | -267 | -386 | N/A | N/A | N/A |
Other Investing Activity | -329 | -386 | 0 | 0 | 0 |
Investing Cash Flow | $-477 | $-386 | $-536 | $-9,582 | $-65 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 425 | 602 | N/A |
Debt Issued | 1,955 | N/A | N/A | 1,000 | 450 |
Debt Repayment | N/A | N/A | N/A | -1,000 | N/A |
Common Stock Issued | 4,344 | 4,643 | 1,887 | 13,295 | 10 |
Other Financing Activity | 0 | 0 | 38 | -507 | 0 |
Financing Cash Flow | $6,299 | $4,643 | $2,350 | $13,390 | $460 |
Beginning Cash Position | 2,143 | 58 | 4,931 | 1,858 | 1,039 |
End Cash Position | 1,810 | 2,143 | 731 | 4,931 | 1,858 |
Net Cash Flow | $-333 | $2,085 | $-4,200 | $3,073 | $819 |
Free Cash Flow | |||||
Operating Cash Flow | -6,155 | -2,172 | -6,014 | -735 | 423 |
Capital Expenditure | -148 | N/A | -536 | -70 | -65 |
Free Cash Flow | -6,303 | -2,172 | -6,550 | -805 | 359 |